Prokera Slim approved for use in Taiwan
Click Here to Manage Email Alerts
Bio-Tissue announced the approval of the Prokera Slim corneal bandage for use by eye care professionals in Taiwan.
The Prokera Slim is a low-profile amniotic membrane corneal bandage that contours to the ocular surface to improve comfort and long-term outcomes during healing processes, according to a press release.
Prokera was cleared by the FDA in 2003. It contains cryopreserved amniotic membrane that acts in anti-inflammatory, anti-scarring and anti-angiogenic capacities on the ocular surface.
“Clinical research has shown us that 70% of eyes re-epithelialized by day 5 with Prokera Slim vs. only 20% with a bandage contact lens. Additionally, 90% of eyes achieved absolute corneal clarity by day 7 with Prokera Slim vs. 0% with a bandage contact lens. That is significant for clinical and patient outcomes,” Scheffer Tseng, MD, PhD, co-founder and chief technology officer at Bio-Tissue, said in the release.
The product is distributed by Orient EuroPharma in Taiwan.